Posts Tagged ‘medications’

Evidence that potential blockbuster weight loss drug Acomplia (rimonabant) causes neurological and psychiatric problems and increases the risk of suicide has led to a unanimous vote against the drug by a US FDA advisory panel. Although rimonabant is already being marketed in 37 countries, it is now unlikely the FDA will approve the weight loss drug, to have been sold in the United States under the name ‘Zimulti’, without more positive data on safety.

If you’ve searched our database of clinical trials research exploring drug safety and efficacy, you’ll know the search facility can quickly zero in on relevant drug research. But what if you’d just like to browse through trials by condition or by sponsor, or just find out about trials with a particular status?

Parents continue to experience problems removing the backing of the new Daytrana patch for ADHD, according to user feedback collected at CounsellingResource.com. Nonetheless, we’ve received three times as many reports of positive overall experiences as reports of negative experiences with Daytrana. Our users have also contributed several suggestions about removing the Daytrana patch adhesive from the skin, and many questions about using the medication. For example, is it OK to cut the patches in half or thirds?

Not enough is known about the potential dangers associated with antidepressant medications, according to the UK’s Mental Health Foundation. The group has responded to the controversy about the GlaxoSmithKline Seroxat case covered in an expose by the Panorama programme.

Interesting developments in mental health news last week include the first skin patch for treating Alzheimer’s disease, an FDA public health warning about serotonin syndrome from combining certain anti-depressants with certain headache medications, and word of apparently serious conflicts of interest at two major medical journals publishing studies about vagus nerve stimulation and about the use of antidepressants during pregnancy.